In adenocarcinoma stromal cells, 45% (45/100) of cases showed PDGFRα overexpression, 52% (52/100 cases) showed a low expression and 3% (3/100 cases) showed an absence of PDGFRα expression. This evidence concerns the gene PDGFRA and adenocarcinoma.